Page last updated: 2024-08-23

nicorandil and DDD MPGNII

nicorandil has been researched along with DDD MPGNII in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirata, M; Ishizuka, N; Kanada, H; Kataoka, M; Moriguchi, Y; Serizawa, K; Sudo, H; Tashiro, Y; Yogo, K; Yorozu, K	1

Other Studies

1 other study(ies) available for nicorandil and DDD MPGNII

Article	Year
Nicorandil improves glomerular injury in rats with mesangioproliferative glomerulonephritis via inhibition of proproliferative and profibrotic growth factors. Journal of pharmacological sciences, 2009, Volume: 111, Issue:1 Topics: Animals; Blood Pressure; Cardiotonic Agents; Cell Proliferation; Collagen Type I; Disease Models, Animal; Fibronectins; Glomerulonephritis, Membranoproliferative; Isoantibodies; Kidney Glomerulus; Male; Nicorandil; Organ Size; Platelet-Derived Growth Factor; Proteinuria; Rats; Rats, Inbred F344; Transforming Growth Factor beta	2009

Article

Year

Nicorandil improves glomerular injury in rats with mesangioproliferative glomerulonephritis via inhibition of proproliferative and profibrotic growth factors.

Journal of pharmacological sciences, 2009, Volume: 111, Issue:1

Topics: Animals; Blood Pressure; Cardiotonic Agents; Cell Proliferation; Collagen Type I; Disease Models, Animal; Fibronectins; Glomerulonephritis, Membranoproliferative; Isoantibodies; Kidney Glomerulus; Male; Nicorandil; Organ Size; Platelet-Derived Growth Factor; Proteinuria; Rats; Rats, Inbred F344; Transforming Growth Factor beta

2009